Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 194 of 1,261
  1. US 11654124

    Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

    AMNEAL PHARMACEUTICALS LLC · Granted May 23, 2023 · Expires May 18, 2043

    granted
  2. US 11654193

    Cancer treatment combinations

    The Regents of the University of California · Granted May 23, 2023 · Expires May 18, 2043

    granted
  3. US 11654187

    Horn fly protein as active antigen in anti-horn fly vaccine for protection of bovines against horn fly infestations

    The United States of America, as represented by the Secretary of Agriculture · Granted May 23, 2023 · Expires May 18, 2043

    granted
  4. US 11654157

    Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation

    Shuttle Pharmaceuticals, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  5. US 11654182

    Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted May 23, 2023 · Expires May 18, 2043

    granted
  6. US 11654147

    ALK2 inhibitors and methods for inhibiting BMP signaling

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 23, 2023 · Expires May 18, 2043

    granted
  7. US 11655282

    Chimeric engulfment receptor molecules

    Cero Therapeutics Holdings, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  8. US 11654097

    Peptide having activities of skin whitening and uses thereof

    CAREGEN CO., LTD. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  9. US 11655455

    Enhanced systems for cell-mediated oncolytic viral therapy

    Calidi Biotherapeutics, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  10. US 11654166

    Therapeutic bacteriophage compositions for treating Staphylococcus infection

    Armata Pharmaceuticals, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  11. CA 3240096

    POLYTHERAPIE POUR LE TRAITEMENT DU CANCER DU POUMON

    NOVARTIS AG [CH] · Granted May 19, 2023 · Expires May 14, 2043

    granted
  12. US 11649438

    Methods and compositions for treating cancer

    CRISPR THERAPEUTICS AG · Granted May 16, 2023 · Expires May 11, 2043

    granted
  13. US 11648297

    Bioresponsive particles

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted
  14. US 11649237

    Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition

    The Regents of the University of California · Granted May 16, 2023 · Expires May 11, 2043

    granted
  15. US 11648274

    Polypeptide

    AUTOLUS LIMITED · Granted May 16, 2023 · Expires May 11, 2043

    granted
  16. US 11649273

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  17. US 11649206

    Method for producing pyrrole compound

    Takeda Pharmaceutical Company Limited · Granted May 16, 2023 · Expires May 11, 2043

    granted
  18. US 11648307

    Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted
  19. US 11648304

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  20. US 11648318

    Anti-transferrin receptor (TFR) antibody and uses thereof

    Dyne Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  21. US 11648247

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  22. US 11649454

    Single-stranded RNA-editing oligonucleotides

    ProQR Therapeutics II B.V. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  23. US 11648245

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted May 16, 2023 · Expires May 11, 2043

    granted
  24. US 11649239

    Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

    Medshine Discovery Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.